Niagen Bioscience, Inc. Common Stock
NAGE • NASDAQ
Niagen Bioscience, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Robert N. Fried, with a market cap of $358.8M.
Market Cap$358.8M
CEORobert N. Fried
CountryUnited States of America
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
NAG
Niagen Bioscience, Inc. Common Stock FAQ
Common questions about Niagen Bioscience, Inc. Common Stock
Niagen Bioscience, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $30.1M.